A 'family spat' spills out in public, as scientists debate effort to build a human genome
By Andrew Joseph,
STAT News
| 06. 04. 2016
Untitled Document
NEW YORK — Harvard Medical School’s George Church and Stanford University’s Drew Endy are top scientists who have expanded the boundaries of biology with their pioneering discoveries. They have written papers together and even cofounded a synthetic biology company.
But over the past month, they have been cast as the opposing spokesmen in the debate over whether scientists should try to build human and other genomes from scratch, a project that could transform our understanding of the basic building blocks of life but that is fraught with ethical issues.
...
But the project raises thorny ethical questions. Although it’s not a goal of the project, in theory, brewing up a complete human genome could lead to the formation of an actual person, sans parents. The effort, in other words, picks at the most fundamental question of our identity: What does it mean to be human?
Continue reading on STAT News
Image via Wikimedia
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 09.08.2026
It is one of biology’s most ingenious rhythms: Every baby is born young. No matter how much wear and tear their parents’ DNA accumulated over their lifetimes, reproduction erases the molecular scars, handing a clean slate to the next generation...
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...